BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32398281)

  • 1. COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
    Bozzalla Cassione E; Zanframundo G; Biglia A; Codullo V; Montecucco C; Cavagna L
    Ann Rheum Dis; 2020 Oct; 79(10):1382-1383. PubMed ID: 32398281
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
    Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
    Konig MF; Kim AH; Scheetz MH; Graef ER; Liew JW; Simard J; Machado PM; Gianfrancesco M; Yazdany J; Langguth D; Robinson PC;
    Ann Rheum Dis; 2020 Oct; 79(10):1386-1388. PubMed ID: 32381561
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.
    Ramirez GA; Gerosa M; Beretta L; Bellocchi C; Argolini LM; Moroni L; Della Torre E; Artusi C; Nicolosi S; Caporali R; Bozzolo EP; Dagna L;
    Semin Arthritis Rheum; 2020 Oct; 50(5):1150-1157. PubMed ID: 32927376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
    Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
    Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
    Zurita MF; Iglesias Arreaga A; Luzuriaga Chavez AA; Zurita L
    Am J Case Rep; 2020 Sep; 21():e927304. PubMed ID: 32978364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
    Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    Peschken CA
    J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
    Sanchez-Piedra C; Diaz-Torne C; Manero J; Pego-Reigosa JM; Rúa-Figueroa Í; Gonzalez-Gay MA; Gomez-Reino J; Alvaro-Gracia JM;
    Ann Rheum Dis; 2020 Jul; 79(7):988-990. PubMed ID: 32503857
    [No Abstract]   [Full Text] [Related]  

  • 10. Initial Observations of COVID-19 in US Children.
    Agha R; Kojaoghlanian T; Avner JR
    Hosp Pediatr; 2020 Oct; 10(10):902-905. PubMed ID: 32636210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
    Nuño L; Novella Navarro M; Bonilla G; Franco-Gómez K; Aguado P; Peiteado D; Monjo I; Tornero C; Villalba A; Miranda-Carus ME; De Miguel E; Bogas P; Castilla-Plaza A; Bernad-Pineda M; García-Lorenzo E; Rodríguez-Araya T; Balsa A
    Ann Rheum Dis; 2020 Dec; 79(12):1659-1661. PubMed ID: 32606046
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical characteristics of COVID-19 patients combined with allergy.
    Shi W; Gao Z; Ding Y; Zhu T; Zhang W; Xu Y
    Allergy; 2020 Sep; 75(9):2405-2408. PubMed ID: 32506509
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smell and taste dysfunction in patients with COVID-19.
    Xydakis MS; Dehgani-Mobaraki P; Holbrook EH; Geisthoff UW; Bauer C; Hautefort C; Herman P; Manley GT; Lyon DM; Hopkins C
    Lancet Infect Dis; 2020 Sep; 20(9):1015-1016. PubMed ID: 32304629
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak.
    Wang Y; Kang H; Liu X; Tong Z
    J Med Virol; 2020 Jun; 92(6):538-539. PubMed ID: 32096564
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster.
    Zayet S; Kadiane-Oussou NJ; Lepiller Q; Zahra H; Royer PY; Toko L; Gendrin V; Klopfenstein T
    Microbes Infect; 2020 Oct; 22(9):481-488. PubMed ID: 32561409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
    de Luca Montes RA; Huq M; Godfrey T; Oon S; Calderone A; Kandane-Rathnayake R; Louthrenoo W; Luo SF; Jan Wu YJ; Golder V; Lateef A; Navarra SV; Zamora L; Hamijoyo L; Sockalingam S; An Y; Li Z; Katsumata Y; Harigai M; Chan M; Goldblatt F; O'Neill S; Lau CS; Cho J; Hoi A; Karyekar CS; Morand EF; Nikpour M
    Adv Rheumatol; 2024 May; 64(1):38. PubMed ID: 38720354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anosmia in COVID-19 patients.
    Hornuss D; Lange B; Schröter N; Rieg S; Kern WV; Wagner D
    Clin Microbiol Infect; 2020 Oct; 26(10):1426-1427. PubMed ID: 32447049
    [No Abstract]   [Full Text] [Related]  

  • 19. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.
    Liguori C; Pierantozzi M; Spanetta M; Sarmati L; Cesta N; Iannetta M; Ora J; Mina GG; Puxeddu E; Balbi O; Pezzuto G; Magrini A; Rogliani P; Andreoni M; Mercuri NB
    Brain Behav Immun; 2020 Aug; 88():11-16. PubMed ID: 32416289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis.
    Wagner T; Shweta F; Murugadoss K; Awasthi S; Venkatakrishnan AJ; Bade S; Puranik A; Kang M; Pickering BW; O'Horo JC; Bauer PR; Razonable RR; Vergidis P; Temesgen Z; Rizza S; Mahmood M; Wilson WR; Challener D; Anand P; Liebers M; Doctor Z; Silvert E; Solomon H; Anand A; Barve R; Gores G; Williams AW; Morice WG; Halamka J; Badley A; Soundararajan V
    Elife; 2020 Jul; 9():. PubMed ID: 32633720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.